Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “First Relapse/Progression”

21 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 21 results

Not applicableUnknownNCT03977623
What this trial is testing

Genomic Evaluation in Patients With Diffuse Large B Cell Lymphoma After First Relapse/Progression

Who this might be right for
Lymphoma, Large B-Cell, Diffuse
Samsung Medical Center 200
Testing effectiveness (Phase 2)UnknownNCT01520558
What this trial is testing

CNDO-109-AANK for AML in First Complete Remission (CR1)

Who this might be right for
Acute Myeloid Leukemia
Coronado Biosciences, Inc. 12
Testing effectiveness (Phase 2)UnknownNCT00530140
What this trial is testing

Idiotypic Vaccination for Follicular Lymphoma Patients

Who this might be right for
Follicular LymphomaFirst Relapse/Progression
Clinica Universidad de Navarra, Universidad de Navarra 100
Testing effectiveness (Phase 2)Study completedNCT00823524
What this trial is testing

Donor Natural Killer Cells After Donor Stem Cell Transplant in Treating Patients With Advanced Cancer

Who this might be right for
Brain and Central Nervous System TumorsChronic Myeloproliferative DisordersLeukemia+6 more
Asan Medical Center 47
Not applicableLooking for participantsNCT07433400
What this trial is testing

Long-term Progression of Patients Treated and Monitored for Relapsed or Refractory Ph+ ALL

Who this might be right for
Ph Positive ALL
Group for Research in Adult Acute Lymphoblastic Leukemia 500
Not applicableLooking for participantsNCT06252792
What this trial is testing

Dara-PD in the Treatment of Patients With First Relapse of Multiple Myeloma

Who this might be right for
Multiple MyelomaFirst Relapse
FengYan Jin 50
Large-scale testing (Phase 3)Study completedNCT01461928
What this trial is testing

A Study Comparing Maintenance Subcutaneous Rituximab With Observation Only in Participants With Relapsed or Refractory Indolent Non-Hodgkin's Lymphoma Who Had Responded to Rituximab-based Immunochemotherapy Induction and 2-year Maintenance With Subcutaneous Rituximab

Who this might be right for
Non-Hodgkin's Lymphoma
Hoffmann-La Roche 692
Testing effectiveness (Phase 2)Study completedNCT01259869
What this trial is testing

PX-866 in Patients With Glioblastoma Multiforme at Time of First Relapse or Progression

Who this might be right for
Glioblastoma
NCIC Clinical Trials Group 34
Early research (Phase 1)Ended earlyNCT00516282
What this trial is testing

VNP40101M and Temozolomide in Treating Patients With Progressive or Relapsed Malignant Glioma

Who this might be right for
Brain and Central Nervous System Tumors
Northwestern University 14
Large-scale testing (Phase 3)Ended earlyNCT05675319
What this trial is testing

Allogeneic Stem Cell Transplantation vs. Conventional Therapy as Salvage Therapy for Relapsed / Progressive Patients With Multiple Myeloma After First-line Therapy

Who this might be right for
Multiple Myeloma
Universitätsklinikum Hamburg-Eppendorf 28
Testing effectiveness (Phase 2)Study completedNCT02769832
What this trial is testing

Nab-Paclitaxel With Gemcitabine for Relapsed Small Cell Cancer

Who this might be right for
Small Cell Lung Cancer (SCLC)
Muhammad Furqan 32
Not applicableEnded earlyNCT01794572
What this trial is testing

Phase 1-2 Study of Total Bone Marrow Irradiation With Helicoidal Tomotherapy in 1st Myeloma Relapse

Who this might be right for
Multiple Myeloma in Relapse
Institut Cancerologie de l'Ouest 13
Testing effectiveness (Phase 2)WithdrawnNCT00797940
What this trial is testing

Convection Enhanced Localized Administration of PRX321 With Real-time Imaging for Therapy of Recurrent Glioblastoma (CLARITY-1)

Who this might be right for
Glioblastoma Multiforme
Sophiris Bio Corp
Testing effectiveness (Phase 2)Ended earlyNCT02008006
What this trial is testing

BENdamustine at Elevated Dose for Relapsed Follicular Lymphoma in Intensification Therapy and Transplantation (BENEFIT)

Who this might be right for
Follicular Lymphoma
Centre Leon Berard 21
Testing effectiveness (Phase 2)Study completedNCT01164995
What this trial is testing

Study With Wee-1 Inhibitor AZD1775 (MK-1775) and Carboplatin to Treat p53 Mutated Refractory and Resistant Ovarian Cancer

Who this might be right for
Epithelial Ovarian Cancer
The Netherlands Cancer Institute 24
Not applicableStudy completedNCT01980212
What this trial is testing

Tumor Relapsed Study of Serum Trxr Activity in Advanced Non-small Cell Lung Cancer

Who this might be right for
Advanced Non-small Cell Lung CancerFirst Line TreatmentThioredoxin Reductase Activity+2 more
Hunan Province Tumor Hospital 500
Not applicableLooking for participantsNCT04055220
What this trial is testing

Efficacy and Safety of Regorafenib as Maintenance Therapy After First-line Treatment in Patients With Bone Sarcomas

Who this might be right for
Bone SarcomaOsteosarcomaEwing Sarcoma+4 more
Centre Leon Berard 168
Large-scale testing (Phase 3)Study completedNCT03366272
What this trial is testing

Nivolumab With Gemcitabine, Oxaliplatin + Rituximab in r/r Elderly Lymphoma Patients

Who this might be right for
Lymphoma, Non-Hodgkin
Universität des Saarlandes 348
Early research (Phase 1)Study completedNCT02135406
What this trial is testing

CART-19 for Multiple Myeloma

Who this might be right for
Multiple Myeloma
University of Pennsylvania 13
Testing effectiveness (Phase 2)Study completedNCT00475670
What this trial is testing

Herceptin (Trastuzumab) in Women With Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Hoffmann-La Roche 44
Next Page